The -308G/A tumor necrosis factor-α gene dimorphism:: A risk factor for unstable angina

被引:43
作者
Bernard, V
Pillois, X
Dubus, I
Benchimol, D
Labouyrie, JP
Couffinhal, T
Coste, P
Bonnet, J
机构
[1] INSERM, U441, Inst Federat Rech Heart Lung Vessel Thrombosis 4, Pessac, France
[2] Univ Bordeaux 2, UFR Pharm, Lab Fundamental & Clin Biochem, F-33076 Bordeaux, France
关键词
acute coronary syndrome; unstable angina; tumor necrosis factor-alpha; gene polymorphism; body mass index;
D O I
10.1515/CCLM.2003.077
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Since the inflammatory cytokine tumor necrosis factor-alpha (TNF-alpha) may play a major role in the pathophysiology of acute coronary syndromes, 299 consecutive male patients hospitalized for coronary artery disease (i.e., lumen lost = 50%) were genotyped for the functional 308G/A TNF[alpha] polymorphism using restriction fragment length polymorphism method, in order to evaluate its potential association with the risk of unstable angina and/or myocardial infarction. A higher frequency of carriers of the A allele was observed in patients with unstable angina (n = 58) when compared to control patients with stable angina (n = 95) (39.66% vs. 23.16% respectively, p = 0.029, odds ratio = 2.2) but not in patients with myocardial infarction (n = 146) (23.97% vs. 23.16%, p = NS). Furthermore, we evidenced an interaction of the polymorphism studied with body mass index in patients with unstable angina. Thus, when stratified analysis was performed, results in patients with a body mass index = 27 showed a more striking association between A allele carriage frequency and unstable angina (p = 0.012, odds ratio = 3.0). These results suggest the crucial role of TNF-alpha in the mechanisms responsible for unstable angina in accordance with the concept of vulnerable plaque. On the other hand, mechanisms controlling myocardial infarction appear more complex and heterogeneous.
引用
收藏
页码:511 / 516
页数:6
相关论文
共 46 条
  • [1] Impact of the-308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: relevance to disease
    Abraham, LJ
    Kroeger, KM
    [J]. JOURNAL OF LEUKOCYTE BIOLOGY, 1999, 66 (04) : 562 - 566
  • [2] ABRAHAM LJ, 1993, CLIN EXP IMMUNOL, V92, P14
  • [3] ARBUSTINI E, 1991, AM J CARDIOL, V68, P36
  • [4] Ardissino D, 1999, BLOOD, V94, P46
  • [5] DETECTION AND LOCALIZATION OF TUMOR NECROSIS FACTOR IN HUMAN ATHEROMA
    BARATH, P
    FISHBEIN, MC
    CAO, J
    BERENSON, J
    HELFANT, RH
    FORRESTER, JS
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1990, 65 (05) : 297 - 302
  • [6] SERUM TUMOR-NECROSIS-FACTOR LEVELS IN ACUTE MYOCARDIAL-INFARCTION AND UNSTABLE ANGINA-PECTORIS
    BASARAN, Y
    BASARAN, MM
    BABACAN, KF
    ENER, B
    OKAY, T
    GOK, H
    OZDEMIR, M
    [J]. ANGIOLOGY, 1993, 44 (04) : 332 - 337
  • [7] Tumor necrosis factor-α-308 G/A polymorphism in obese Caucasians
    Brand, E
    Schorr, U
    Kunz, I
    Kertmen, E
    Ringel, J
    Distler, A
    Sharma, AM
    [J]. INTERNATIONAL JOURNAL OF OBESITY, 2001, 25 (04) : 581 - 585
  • [8] Ageing, tumour necrosis factor-alpha (TNF-α) and atherosclerosis
    Bruunsgaard, H
    Skinhoj, P
    Pedersen, AN
    Schroll, M
    Pedersen, BK
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2000, 121 (02) : 255 - 260
  • [9] Metformin increases circulating tumour necrosis factor-α levels in non-obese non-diabetic patients with coronary heart disease
    Carlsen, SM
    Waage, A
    Grill, V
    Folling, I
    [J]. CYTOKINE, 1998, 10 (01) : 66 - 69
  • [10] Collins JS, 2000, AM J MED GENET, V96, P823, DOI 10.1002/1096-8628(20001204)96:6<823::AID-AJMG26>3.0.CO